NEW DELHI, April 21 (Reuters) - The Serum Institute of India
will be able to raise its monthly output of the AstraZeneca
COVID-19 vaccine to 100 million doses by July from 60-70 million
now, later than a previous timeline of end-May, its chief
executive Adar Poonawalla told CNBC-TV18.
(Reporting by Chandini Monappa and Krishna N. Das; Editing by
Andrew Heavens)
LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend
(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.
Read more